Literature DB >> 18959744

Ligand binding promotes prion protein aggregation--role of the octapeptide repeats.

Shuiliang Yu1, Shaoman Yin, Nancy Pham, Poki Wong, Shin-Chung Kang, Robert B Petersen, Chaoyang Li, Man-Sun Sy.   

Abstract

Aggregation of the normal cellular prion protein, PrP, is important in the pathogenesis of prion disease. PrP binds glycosaminoglycan (GAG) and divalent cations, such as Cu(2+) and Zn(2+). Here, we report our findings that GAG and Cu(2+) promote the aggregation of recombinant human PrP (rPrP). The normal cellular prion protein has five octapeptide repeats. In the presence of either GAG or Cu(2+), mutant rPrPs with eight or ten octapeptide repeats are more aggregation prone, exhibit faster kinetics and form larger aggregates than wild-type PrP. When the GAG-binding motif, KKRPK, is deleted the effect of GAG but not that of Cu(2+) is abolished. By contrast, when the Cu(2+)-binding motif, the octapeptide-repeat region, is deleted, neither GAG nor Cu(2+) is able to promote aggregation. Therefore, the octapeptide-repeat region is critical in the aggregation of rPrP, irrespective of the promoting ligand. Furthermore, aggregation of rPrP in the presence of GAG is blocked with anti-PrP mAbs, whereas none of the tested anti-PrP mAbs block Cu(2+)-promoted aggregation. However, a mAb that is specific for an epitope at the N-terminus enhances aggregation in the presence of either GAG or Cu(2+). Therefore, although binding of either GAG or Cu(2+) promotes the aggregation of rPrP, their aggregation processes are different, suggesting multiple pathways of rPrP aggregation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18959744      PMCID: PMC2648294          DOI: 10.1111/j.1742-4658.2008.06680.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  52 in total

1.  Octapeptide repeat insertions in the prion protein gene and early onset dementia.

Authors:  E A Croes; J Theuns; J J Houwing-Duistermaat; B Dermaut; K Sleegers; G Roks; M Van den Broeck; B van Harten; J C van Swieten; M Cruts; C Van Broeckhoven; C M van Duijn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-08       Impact factor: 10.154

2.  Cellular prion protein acquires resistance to proteolytic degradation following copper ion binding.

Authors:  Thorsten Kuczius; Anne Buschmann; Wenlan Zhang; Helge Karch; Karsten Becker; Georg Peters; Martin H Groschup
Journal:  Biol Chem       Date:  2004-08       Impact factor: 3.915

3.  Structural clues to prion replication.

Authors:  F E Cohen; K M Pan; Z Huang; M Baldwin; R J Fletterick; S B Prusiner
Journal:  Science       Date:  1994-04-22       Impact factor: 47.728

4.  Mutations of the prion protein gene phenotypic spectrum.

Authors:  Gábor G Kovács; Gianriccardo Trabattoni; Johannes A Hainfellner; James W Ironside; Richard S G Knight; Herbert Budka
Journal:  J Neurol       Date:  2002-11       Impact factor: 4.849

5.  Copper and zinc cause delivery of the prion protein from the plasma membrane to a subset of early endosomes and the Golgi.

Authors:  Lesley R Brown; David A Harris
Journal:  J Neurochem       Date:  2003-10       Impact factor: 5.372

6.  Preferential Cu2+ coordination by His96 and His111 induces beta-sheet formation in the unstructured amyloidogenic region of the prion protein.

Authors:  Christopher E Jones; Salama R Abdelraheim; David R Brown; John H Viles
Journal:  J Biol Chem       Date:  2004-05-15       Impact factor: 5.157

7.  Inter- and intra-octarepeat Cu(II) site geometries in the prion protein: implications in Cu(II) binding cooperativity and Cu(II)-mediated assemblies.

Authors:  Silvia Morante; Reinerio González-Iglesias; Cristina Potrich; Carlo Meneghini; Wolfram Meyer-Klaucke; Gianfranco Menestrina; María Gasset
Journal:  J Biol Chem       Date:  2003-12-31       Impact factor: 5.157

8.  Sulfated glycosaminoglycans in amyloid plaques of prion diseases.

Authors:  A D Snow; R Kisilevsky; J Willmer; S B Prusiner; S J DeArmond
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

9.  The octapeptide repeats in mammalian prion protein constitute a pH-dependent folding and aggregation site.

Authors:  Ralph Zahn
Journal:  J Mol Biol       Date:  2003-11-28       Impact factor: 5.469

10.  Copper binding to PrPC may inhibit prion disease propagation.

Authors:  Nuha Hijazi; Yuval Shaked; Hana Rosenmann; Tamir Ben-Hur; Ruth Gabizon
Journal:  Brain Res       Date:  2003-12-12       Impact factor: 3.252

View more
  10 in total

1.  Do prion protein gene polymorphisms induce apoptosis in non-mammals?

Authors:  Tuğçe Birkan; Mesut Şahin; Zubeyde Öztel; Erdal Balcan
Journal:  J Biosci       Date:  2016-03       Impact factor: 1.826

2.  Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.

Authors:  Bradley M Coleman; Christopher F Harrison; Belinda Guo; Colin L Masters; Kevin J Barnham; Victoria A Lawson; Andrew F Hill
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

3.  A multistage pathway for human prion protein aggregation in vitro: from multimeric seeds to β-oligomers and nonfibrillar structures.

Authors:  Kang R Cho; Yu Huang; Shuiliang Yu; Shaoman Yin; Marco Plomp; S Roger Qiu; Rajamani Lakshminarayanan; Janet Moradian-Oldak; Man-Sun Sy; James J De Yoreo
Journal:  J Am Chem Soc       Date:  2011-05-17       Impact factor: 15.419

4.  Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions.

Authors:  Abhay Kumar Thakur; Atul Kumar Srivastava; Volety Srinivas; Kandala Venkata Ramana Chary; Chintalagiri Mohan Rao
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

5.  A 2cM genome-wide scan of European Holstein cattle affected by classical BSE.

Authors:  Brenda M Murdoch; Michael L Clawson; William W Laegreid; Paul Stothard; Matthew Settles; Stephanie McKay; Aparna Prasad; Zhiquan Wang; Stephen S Moore; John L Williams
Journal:  BMC Genet       Date:  2010-03-29       Impact factor: 2.797

6.  Loss of Octarepeats in two processed prion pseudogenes in the red squirrel, Sciurus vulgaris.

Authors:  Ole Madsen; Timothy T Kortum; Marlinda Hupkes; Wouter Kohlen; Teun van Rheede; Wilfried W de Jong
Journal:  J Mol Evol       Date:  2010-09-28       Impact factor: 2.395

7.  Instability of the octarepeat region of the human prion protein gene.

Authors:  Baiya Li; Liuting Qing; Jianqun Yan; Qingzhong Kong
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

8.  Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity.

Authors:  Chi-Fu Yen; Dilshan S Harischandra; Anumantha Kanthasamy; Sanjeevi Sivasankar
Journal:  Sci Adv       Date:  2016-07-01       Impact factor: 14.136

9.  Substitutions of PrP N-terminal histidine residues modulate scrapie disease pathogenesis and incubation time in transgenic mice.

Authors:  Sabina Eigenbrod; Petra Frick; Uwe Bertsch; Gerda Mitteregger-Kretzschmar; Janina Mielke; Marko Maringer; Niklas Piening; Alexander Hepp; Nathalie Daude; Otto Windl; Johannes Levin; Armin Giese; Vignesh Sakthivelu; Jörg Tatzelt; Hans Kretzschmar; David Westaway
Journal:  PLoS One       Date:  2017-12-08       Impact factor: 3.240

Review 10.  Recombinant PrP and Its Contribution to Research on Transmissible Spongiform Encephalopathies.

Authors:  Jorge M Charco; Hasier Eraña; Vanessa Venegas; Sandra García-Martínez; Rafael López-Moreno; Ezequiel González-Miranda; Miguel Ángel Pérez-Castro; Joaquín Castilla
Journal:  Pathogens       Date:  2017-12-14
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.